CIBC Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$403K Hold
3,650
– – ﹤0.01% 872
2026
Q2
$286K Sell
3,650
-316
-8% -$21.5K ﹤0.01% 1082
2026
Q1
$256K Hold
3,966
– – ﹤0.01% 1074
2025
Q4
$267K Hold
3,966
– – ﹤0.01% 1042
2025
Q3
$291K Hold
3,966
– – ﹤0.01% 942
2025
Q2
$206K Hold
3,966
– – ﹤0.01% 1106
2025
Q1
$253K Buy
+3,966
New +$230K ﹤0.01% 946
2024
Q4
– Sell
-3,691
Closed -$211K – 1252
2024
Q3
$211K Buy
+3,691
New +$212K ﹤0.01% 1083
2023
Q1
– Sell
-3,641
Closed -$207K – 1097
2022
Q4
$207K Sell
3,641
-2,019
-36% -$103K ﹤0.01% 930
2022
Q3
$224K Hold
5,660
– – ﹤0.01% 1024
2022
Q2
$249K Sell
5,660
-414
-7% -$17.9K ﹤0.01% 977
2022
Q1
$242K Hold
6,074
– – ﹤0.01% 1197
2021
Q4
$244K Buy
6,074
+285
+5% +$10.6K ﹤0.01% 1222
2021
Q3
$235K Buy
5,789
+758
+15% +$31.7K ﹤0.01% 1216
2021
Q2
$228K Hold
5,031
– – ﹤0.01% 1192
2021
Q1
$210K Sell
5,031
-716
-12% -$32.7K ﹤0.01% 1218
2020
Q4
$245K Buy
+5,747
New +$207K ﹤0.01% 1008

Other funds holding HALO

CIBC Asset Management's HALO Position: Q3 2026 in Review

CIBC Asset Management held its Halozyme (HALO) position steady in Q3 2026 at 3,650 shares worth $403K. The position accounts for ﹤0.01% of the portfolio, ranked #872.

CIBC Asset Management first reported a position in HALO in Q4 2020 and has held it in 17 quarters since. 636 funds tracked by Wall St. Rank hold HALO as of Q3 2026.

  • CIBC Asset Management held 3,650 shares of Halozyme worth $403K as of Q3 2026.
  • CIBC Asset Management left its Halozyme share count unchanged in Q3 2026.
  • Halozyme made up ﹤0.01% of CIBC Asset Management's portfolio in Q3 2026, its #872 holding.
  • CIBC Asset Management first reported a position in Halozyme in Q4 2020 and has held it in 17 quarters since.
  • 636 funds tracked by Wall St. Rank held Halozyme as of Q3 2026.

Based on CIBC Asset Management's 13F filing for Q3 2026, filed 5 Nov 2026.